AstraZeneca COVID vaccine pause seen as 'Mixed blessing' for competitors

SVB Leerink analyst Andrew Berens believes the overall pace of many other COVID programs could also be impacted.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.